首页>
外国专利>
USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF TEMPORAL LOBE EPILEPSY
USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF TEMPORAL LOBE EPILEPSY
展开▼
机译:在颞叶癫痫治疗中使用大麻制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of a cannabidiol (CBD) preparation in the treatment of temporal lobe epilepsy. In particular the CBD preparation is characterized by chemical components and/or functional properties that distinguish them from prior CBD compositions. Preferably the CBD used is in the form of a botanically derived purified CBD which comprises greater than or equal to 98% (w/w) CBD and less than or equal to 2% (w/w) of other cannabinoids. The other cannabinoids present are THC at a concentration of less than or equal to 0.1% (w/w); CBD-C1 at a concentration of less than or equal to 0.15% (w/w); CBDV at a concentration of less than or equal to 0.8% (w/w); and CBD-C4 at a concentration of less than or equal to 0.4% (w/w). The botanically derived purified CBD preferably also comprises a mixture of both trans-THC and cis-THC. Alternatively, a synthetically produced CBD is used.
展开▼